UBS raised the firm’s price target on Ovintiv (OVV) to $54 from $52 and keeps a Buy rating on the shares. Ovintiv is on a clear path for valuation creation, the analyst tells investors in a research note.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OVV:
- Ovintiv price target lowered to $52 from $54 at Citi
- Ovintiv price target raised to $42 from $38 at Wells Fargo
- Nuvista Energy downgraded to Hold from Buy at Jefferies
- Nuvista Energy downgraded to Market Perform from Outperform at BMO Capital
- Ovintiv Announces Acquisition Agreement with NuVista Energy
